G LP-1 drugs containing semaglutide (the active ingredient in Ozempic and Wegovy) have exploded in popularity for their ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

Ozempic is approved to reduce the risk of heart attack or stroke in people with type 2 diabetes and heart disease. It’s also approved to reduce the risk of kidney disease progression or heart ...

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...

Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...

Acclaimed vocalist Michael Trotter Jr. of the husband-and-wife duo The War and Treaty, reveals his diabetes diagnosis in ...